Explain this page
Arphra AIPlain-English read on Ralph Lauren Corporation’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +65.02% | +66.70% | +64.65% | +66.83% | +68.55% | +67.51% | +66.72% | +64.79% | +66.34% |
| Operating margin | -0.99% | +12.84% | +10.93% | +11.41% | +13.17% | +11.70% | +11.56% | +12.09% | +11.73% |
| EBITDA margin | +5.03% | +16.70% | +14.79% | +15.81% | +17.15% | +15.69% | +15.85% | +15.55% | +16.18% |
| EBIT margin | -0.60% | +13.00% | +11.36% | +12.36% | +14.05% | +12.60% | +12.29% | +12.67% | +12.93% |
| Pre-tax margin | -1.70% | +12.13% | +10.74% | +11.72% | +13.43% | +11.96% | +12.30% | +11.61% | +11.95% |
| Net margin | -2.75% | +9.65% | +8.11% | +9.75% | +10.49% | +9.24% | +9.40% | +9.30% | +9.20% |
| Cost structure | |||||||||
| Cost of revenue / sales | +34.98% | +33.30% | +35.35% | +33.17% | +31.45% | +33.63% | +33.80% | +32.62% | +33.24% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | +60.21% | +53.16% | +52.90% | +54.29% | +54.57% | +53.18% | +54.40% | +54.31% | +52.50% |
| Effective tax rate | — | +20.47% | +24.45% | +16.86% | +21.86% | +20.53% | +20.73% | +21.83% | +20.71% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | -4.65% | +23.66% | +21.51% | +26.38% | +28.70% | +25.06% | +25.22% | +24.51% | +25.06% |
| Return on assets (ROA) | -1.54% | +7.77% | +7.70% | +9.79% | +10.54% | +8.87% | +9.05% | +9.16% | +8.99% |
| Return on capital (ROC) | -0.70% | +13.47% | +10.91% | +12.32% | +17.73% | +13.29% | +13.06% | +13.24% | +13.23% |
| Return on invested capital (ROIC) | -0.53% | +10.12% | +8.10% | +10.53% | +14.13% | +10.49% | +10.62% | +10.18% | +10.37% |
| Asset turnover | +55.79% | +80.50% | +94.91% | +100.44% | +100.45% | +95.97% | +96.27% | +98.51% | +97.78% |
| DuPont · ROE decomposition | |||||||||
| Net margin | -2.75% | +9.65% | +8.11% | +9.75% | +10.49% | +9.24% | +9.40% | +9.30% | +9.20% |
| Asset turnover (× revenue / assets) | +55.79% | +80.50% | +94.91% | +100.44% | +100.45% | +95.97% | +96.27% | +98.51% | +97.78% |
| Equity multiplier (× assets / equity) | +302.85% | +304.60% | +279.35% | +269.46% | +272.25% | +282.61% | +278.59% | +267.70% | +278.65% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 0.56 | 0.81 | 0.95 | 1.00 | 1.00 | 0.96 | 0.96 | 0.99 | 0.98 |
| Fixed-asset turnover | 1.95 | 2.99 | 3.08 | 3.56 | 3.81 | — | — | — | — |
| Inventory turnover | 2.03 | 2.12 | 2.13 | 2.44 | 2.34 | — | — | — | — |
| Receivables turnover | 7.70 | 11.46 | 11.12 | 11.82 | 11.56 | — | — | — | — |
| Payables turnover | 4.33 | 4.62 | 6.13 | 6.62 | 5.11 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 47.43 | 31.86 | 32.84 | 30.88 | 31.57 | — | — | — | — |
| Days inventory outstanding (DIO) | 179.96 | 172.24 | 171.67 | 149.71 | 155.70 | — | — | — | — |
| Days payables outstanding (DPO) | 84.39 | 79.08 | 59.55 | 55.13 | 71.49 | — | — | — | — |
| Cash conversion cycle | 143.01 | 125.02 | 144.96 | 125.46 | 115.78 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | -3.15 | 1.19 | 0.79 | 1.66 | 1.66 | 1.43 | 1.40 | 1.39 | 1.42 |
| FCF / Net income | -2.26 | 0.91 | 0.37 | 1.40 | 1.37 | 1.10 | 1.11 | 1.15 | 1.15 |
| FCF margin | +6.21% | +8.83% | +3.00% | +13.65% | +14.39% | +10.13% | +10.39% | +10.66% | +10.60% |
| OCF margin | +8.66% | +11.51% | +6.38% | +16.13% | +17.45% | +13.25% | +13.18% | +12.93% | +13.10% |
| CapEx / Revenue | +2.45% | +2.68% | +3.38% | +2.49% | +3.05% | +2.89% | +3.03% | +2.94% | +2.98% |
| CapEx / D&A | 0.44 | 0.73 | 0.99 | 0.72 | 0.98 | — | — | — | — |
| Stock-based comp / Revenue | +1.65% | +1.31% | +1.17% | +1.50% | +1.52% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | -1.65 | 8.08 | 7.58 | 9.72 | 11.61 | 18.30 | 20.38 | 22.72 | 23.61 |
| EPS · basic | -1.65 | 8.22 | 7.72 | 9.91 | 11.86 | 18.84 | 20.48 | 23.48 | 24.43 |
| Book value / share | 35.43 | 34.13 | 35.22 | 36.85 | 40.45 | 49.33 | 52.53 | 56.19 | 56.13 |
| Tangible BV / share | 21.07 | 20.52 | 20.91 | 22.35 | 25.58 | 49.33 | 52.53 | 56.19 | 56.13 |
| Sales / share | 59.87 | 83.69 | 93.39 | 99.72 | 110.61 | 133.79 | 140.90 | 148.16 | 152.93 |
| Operating CF / share | 5.18 | 9.64 | 5.96 | 16.09 | 19.30 | 17.72 | 18.57 | 19.16 | 20.03 |
| Free cash flow / share | 3.72 | 7.39 | 2.80 | 13.61 | 15.92 | 13.55 | 14.64 | 15.79 | 16.21 |
| Dividends / share | 0.68 | 2.02 | 2.87 | 2.93 | 3.14 | 3.85 | 4.10 | 4.25 | 4.38 |
| Payout ratio | -41.12% | +25.00% | +37.94% | +30.11% | +27.07% | +31.18% | +30.98% | +30.84% | +31.14% |
| Retention ratio | +141.12% | +75.00% | +62.06% | +69.89% | +72.93% | +68.82% | +69.02% | +69.16% | +68.86% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2027E | 2028E | 2029E | 2030E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +41.30% | +3.62% | +2.91% | +6.75% | +21.30% | +4.97% | +5.47% | +3.73% | +10.61% |
| Gross profit · YoY | — | +44.95% | +0.44% | +6.39% | +9.50% | +19.46% | +3.73% | +2.43% | +6.20% | +10.89% |
| Profit | ||||||||||
| Operating income · YoY | — | +1931.19% | -11.80% | +7.41% | +23.23% | +7.83% | +3.64% | +10.34% | +0.65% | — |
| EBITDA · YoY | — | +369.18% | -8.23% | +10.05% | +15.81% | +10.93% | +6.05% | +3.50% | +7.94% | +28.01% |
| Net income · YoY | — | +595.54% | -12.90% | +23.65% | +14.95% | +6.79% | +6.83% | +4.27% | +2.64% | — |
| Operating | ||||||||||
| EBIT · YoY | — | +3174.52% | -9.44% | +11.92% | +21.38% | +8.75% | +2.36% | +8.79% | +5.86% | — |
| R&D · YoY | — | — | — | — | — | — | — | — | — | — |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | +589.70% | -6.19% | +28.23% | +19.44% | +57.64% | +11.34% | +11.48% | +3.94% | — |
| EPS · basic · YoY | — | +598.18% | -6.08% | +28.37% | +19.68% | +58.87% | +8.67% | +14.69% | +4.01% | — |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $3.62B | $3.39B | $4.02B | $3.69B | $2.67B | $4.4B | $4.62B | $5.08B | $5.13B |
| Net debt | $1.04B | $1.53B | $2.49B | $2.03B | $745.6M | $2.17B | $2.38B | $2.6B | $2.61B |
| Net debt / EBITDA | 4.71 | 1.47 | 2.62 | 1.93 | 0.61 | 1.61 | 1.67 | 1.76 | 1.64 |
| Debt / equity | 1.39 | 1.34 | 1.66 | 1.51 | 1.03 | 1.39 | 1.37 | 1.41 | 1.42 |
| Debt / assets | +45.90% | +43.91% | +59.25% | +55.88% | +37.86% | +49.15% | +49.31% | +52.59% | +50.82% |
| Equity / assets | +33.02% | +32.83% | +35.80% | +37.11% | +36.73% | +35.38% | +35.90% | +37.36% | +35.89% |
| Coverage | |||||||||
| EBITDA / interest expense | 4.56 | 19.23 | 23.58 | 24.85 | 27.54 | 24.67 | 25.03 | 25.10 | 25.70 |
| Operating income / interest | -0.90 | 14.79 | 17.43 | 17.92 | 21.14 | 18.41 | 18.25 | 19.51 | 18.63 |
| Interest expense | $48.5M | $54M | $40.4M | $42.2M | $44.1M | $54.61M | $57.08M | $58.92M | $62.11M |
| Liquidity | |||||||||
| Current ratio | 2.66 | 1.87 | 2.23 | 2.29 | 1.78 | — | — | — | — |
| Quick ratio | 2.11 | 1.39 | 1.44 | 1.60 | 1.26 | — | — | — | — |
| Cash ratio | 1.63 | 0.83 | 1.02 | 1.13 | 0.90 | — | — | — | — |
| Working capital | $2.62B | $1.96B | $1.83B | $1.89B | $1.66B | — | — | — | — |
| Working capital / revenue | +59.61% | +31.54% | +28.41% | +28.54% | +23.40% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).